News
Ethnic differences in stem cell transplants may be narrowing
Major finding: Just 20% of non-white patients in the study had a fully-matched donor available, while 69% of white northern European patients did...
News
Nivolumab activity is durable in advanced melanoma
Major finding: Median overall survival across all doses of nivolumab was 16.8 months.
News
Adding GM-CSF to ipilimumab extends survival in metastatic melanoma
Major finding: One year after the start of therapy, 69% of patients given the combination therapy and 53% of those who got ipilimumab alone were...
